Press release

Mammography reading software from Siemens Healthineers with AI-based decision support for faster results

RSNA 2018 in Chicago: South Hall, Booth #4136

Published on November 26, 2018

*  Syngo.Breast Care VB40 - powered by TransparaTM, ScreenPoint Medical - is currently under development. It is not for sale in the U.S. Its future availability cannot be guaranteed.

** Transpara is currently 510(k) pending for 2D reading.

1

 Rodriguez-Ruiz A., Lång K., Gubern-Merida A., et al.: Detecting breast cancer in mammography: a deep learning-based computer system versus 101 radiologists (Journal of the National Cancer Institute 2018 (Accepted).

Siemens Healthineers 2018

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide.